- Q3 sales $13.01 billion
- Reported growth 14.5%
- Comparable growth 7.0%
- Diagnostics reported growth 46.7%
Abbott reported Q3 sales of $13.01 billion, up 14.5% reported and 7.0% comparable. Diagnostics surged 46.7% on the Exact Sciences acquisition. Medical Devices grew 7.8% comparable. U.S. Diagnostics more than doubled.
One free account opens every story complete, the live board, the 30-day calendar, a watchlist and breaking alerts on your phone. No card. The wire stays free to read.